pubmed-article:10482449 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C0019143 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C0380603 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C0022203 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C1510827 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C0332256 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C0870432 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C1705417 | lld:lifeskim |
pubmed-article:10482449 | lifeskim:mentions | umls-concept:C1555465 | lld:lifeskim |
pubmed-article:10482449 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:10482449 | pubmed:dateCreated | 1999-10-25 | lld:pubmed |
pubmed-article:10482449 | pubmed:abstractText | It has been suggested that the FGF-2 binding site on heparan sulfate chains is a trisulfated pentasaccharide containing three hexuronic acid units. The configuration at C-5 of two of them being undetermined, we have synthesized the four possible pentasaccharides, and have evaluated their FGF-2 binding affinity through in vitro biological assays. The pentasaccharide containing L-iduronic acid as the sole hexuronic acid showed higher affinity for FGF-2 than the other pentasaccharides, where one hexuronic acid unit at least is D-glucuronic acid. | lld:pubmed |
pubmed-article:10482449 | pubmed:language | eng | lld:pubmed |
pubmed-article:10482449 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10482449 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10482449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10482449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10482449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10482449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10482449 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10482449 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10482449 | pubmed:month | Aug | lld:pubmed |
pubmed-article:10482449 | pubmed:issn | 0968-0896 | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:SinaÿPP | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:PetitouMM | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:BonoFF | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:SalmivirtaMM | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:HerbertJ MJM | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:SizunPP | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:KovenskyJJ | lld:pubmed |
pubmed-article:10482449 | pubmed:author | pubmed-author:DuchaussoyPP | lld:pubmed |
pubmed-article:10482449 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10482449 | pubmed:volume | 7 | lld:pubmed |
pubmed-article:10482449 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10482449 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10482449 | pubmed:pagination | 1567-80 | lld:pubmed |
pubmed-article:10482449 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:meshHeading | pubmed-meshheading:10482449... | lld:pubmed |
pubmed-article:10482449 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10482449 | pubmed:articleTitle | A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers. | lld:pubmed |
pubmed-article:10482449 | pubmed:affiliation | Ecole Normale Supérieure, Département de Chimie, Associé au CNRS, Paris, France. | lld:pubmed |
pubmed-article:10482449 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10482449 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10482449 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10482449 | lld:pubmed |